Cagri
Cagri is a peptide agonist of the MC4 receptor studied for appetite suppression and weight loss.
Description
Cagrilintide (Cagri) is an MC4 receptor agonist studied for appetite suppression and metabolic disease treatment.
It mimics natural satiety signals and is being evaluated for anti-obesity effects.
– **Appetite suppression:** Lau et al., 2020 [PMID: 32032549]
Additional information
| Weight | 5 lbs |
|---|
Reviews
There are no reviews yet.